含有嘌呤、香豆素和异恶唑啉或异恶唑基团的新型杂化分子的合成及生物学评价。

Q2 Pharmacology, Toxicology and Pharmaceutics
Open Medicinal Chemistry Journal Pub Date : 2017-11-30 eCollection Date: 2017-01-01 DOI:10.2174/1874104501711010196
Michael G Kallitsakis, Angelo Carotti, Marco Catto, Aikaterini Peperidou, Dimitra J Hadjipavlou-Litina, Konstantinos E Litinas
{"title":"含有嘌呤、香豆素和异恶唑啉或异恶唑基团的新型杂化分子的合成及生物学评价。","authors":"Michael G Kallitsakis,&nbsp;Angelo Carotti,&nbsp;Marco Catto,&nbsp;Aikaterini Peperidou,&nbsp;Dimitra J Hadjipavlou-Litina,&nbsp;Konstantinos E Litinas","doi":"10.2174/1874104501711010196","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The 1,3-dipolar cycloaddition reactions of nitrile oxides formed <i>in situ</i> (in the presence of NCS and Et<sub>3</sub>N) from the oximes of (purin-9-yl)acetaldehyde or (coumarinyloxy)acetaldehyde with allyloxycoumarins or 9-allylpurines, respectively resulted in 3,5-disubstituted isoxazolines. The similar reactions of propargyloxycoumarins or 9-propargylpurines led to 3,5-disubstituted isoxazoles by treatment with PIDA and catalytic amount of TFA.</p><p><strong>Methods: </strong>The new compounds were tested <i>in vitro</i> as antioxidant agents and inhibitors of soybean lipoxygenase LO, AChE and MAO-B.</p><p><strong>Results: </strong>The majority of the compounds showed significant hydroxyl radical scavenging activity. Compounds <b>4k</b> and <b>4n</b> presented LO inhibitory activity.</p><p><strong>Conclusion: </strong>Compound <b>13</b>e presents an antioxidant significant profile combining anti-LO, anti-AChE and anti-MAO-B activities.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"196-211"},"PeriodicalIF":0.0000,"publicationDate":"2017-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874104501711010196","citationCount":"11","resultStr":"{\"title\":\"Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties.\",\"authors\":\"Michael G Kallitsakis,&nbsp;Angelo Carotti,&nbsp;Marco Catto,&nbsp;Aikaterini Peperidou,&nbsp;Dimitra J Hadjipavlou-Litina,&nbsp;Konstantinos E Litinas\",\"doi\":\"10.2174/1874104501711010196\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The 1,3-dipolar cycloaddition reactions of nitrile oxides formed <i>in situ</i> (in the presence of NCS and Et<sub>3</sub>N) from the oximes of (purin-9-yl)acetaldehyde or (coumarinyloxy)acetaldehyde with allyloxycoumarins or 9-allylpurines, respectively resulted in 3,5-disubstituted isoxazolines. The similar reactions of propargyloxycoumarins or 9-propargylpurines led to 3,5-disubstituted isoxazoles by treatment with PIDA and catalytic amount of TFA.</p><p><strong>Methods: </strong>The new compounds were tested <i>in vitro</i> as antioxidant agents and inhibitors of soybean lipoxygenase LO, AChE and MAO-B.</p><p><strong>Results: </strong>The majority of the compounds showed significant hydroxyl radical scavenging activity. Compounds <b>4k</b> and <b>4n</b> presented LO inhibitory activity.</p><p><strong>Conclusion: </strong>Compound <b>13</b>e presents an antioxidant significant profile combining anti-LO, anti-AChE and anti-MAO-B activities.</p>\",\"PeriodicalId\":39133,\"journal\":{\"name\":\"Open Medicinal Chemistry Journal\",\"volume\":\"11 \",\"pages\":\"196-211\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2174/1874104501711010196\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Medicinal Chemistry Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1874104501711010196\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Medicinal Chemistry Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874104501711010196","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 11

摘要

在NCS和Et3N的存在下,由(purin-9-yl)乙醛或(coumarinyloxy)乙醛的肟类与烯丙基香豆素或9-烯丙基嘌呤在原位形成的腈氧化物的1,3-偶极环加成反应,分别生成3,5-二取代异恶唑啉。用PIDA和TFA催化量处理丙基氧香豆素和9-丙基嘌呤,得到3,5-二取代异恶唑。结果:大部分化合物具有明显的羟基自由基清除活性。化合物4k和4n具有LO抑制活性。结论:化合物13e具有显著的抗lo、抗ache和抗mao - b活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties.

Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties.

Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties.

Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties.

Introduction: The 1,3-dipolar cycloaddition reactions of nitrile oxides formed in situ (in the presence of NCS and Et3N) from the oximes of (purin-9-yl)acetaldehyde or (coumarinyloxy)acetaldehyde with allyloxycoumarins or 9-allylpurines, respectively resulted in 3,5-disubstituted isoxazolines. The similar reactions of propargyloxycoumarins or 9-propargylpurines led to 3,5-disubstituted isoxazoles by treatment with PIDA and catalytic amount of TFA.

Methods: The new compounds were tested in vitro as antioxidant agents and inhibitors of soybean lipoxygenase LO, AChE and MAO-B.

Results: The majority of the compounds showed significant hydroxyl radical scavenging activity. Compounds 4k and 4n presented LO inhibitory activity.

Conclusion: Compound 13e presents an antioxidant significant profile combining anti-LO, anti-AChE and anti-MAO-B activities.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Open Medicinal Chemistry Journal
Open Medicinal Chemistry Journal Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
4.40
自引率
0.00%
发文量
4
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信